In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Molecular Insight Pharmaceuticals, Inc.

http://www.molecularinsight.com

Latest From Molecular Insight Pharmaceuticals, Inc.

Gottlieb's Confirmation: Will Industry Ties Remain A Problem After The Hearing?

The US FDA commissioner does not generally get involved with day-to-day activities, former FDA chiefs say, but perception of bias could be a lasting problem.

FDA Regulation

Gottlieb's Confirmation: Will Industry Ties Remain A Big Deal After The Hearing?

The US FDA commissioner does not generally get involved with day-to-day activities, former FDA chiefs say, but perception of bias could be lasting problem.

FDA Leadership

People Briefs

CardioDx appoints president and CEO; FDA device review veteran joins Hogan Lovells; TransEnterix names new senior surgical office; and more personnel updates from around the industry.

Medical Device Business Strategies

US Capitol Capsule: Rare disease research hopeful, but therapy success remains low

It used to be that the FDA's regulatory focus on therapies to treat rare diseases involved only a small segment of the agency's activities.

Metabolic Disorders Cardiovascular
See All

Company Information

UsernamePublicRestriction

Register